Literature DB >> 8564946

Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.

H Tsuchiya1, K Orimoto, K Kobayashi, O Hino.   

Abstract

The Eker rat hereditary renal carcinoma is an excellent example of Mendelian dominant predisposition to a specific cancer in an experimental animal. We recently reported that a germline insertion in the rat homologue of the human tuberous sclerosis gene (TSC2) gives rise to dominantly inherited cancer in the Eker rat model, as well as a tumor suppressor nature for the Tsc2 gene function. We also showed a strong conservation between the rat and human gene products. The molecular function of the Tsc2 gene product (called "tuberin" in the human case) is not yet understood, although it contains a short amino acid sequence homologous to ras family GTPase-activating proteins (Rap1GAP). Here, we describe transcriptional activation domains (AD1 and AD2) in the carboxyl terminus of the Tsc2 product (in exons 30 and 32 and exon 41, respectively). The Eker insertional mutation (intron 30) disrupts their transcriptional activity. Whereas a COOH-terminal truncated Tsc2 protein was localized in the nucleus, the full-length protein is found predominantly in the perinuclear region of cytoplasm. The present demonstration of transcriptional activation domains in the Tsc2 gene provides clues for studying its role in renal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564946

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog.

Authors:  T Kobayashi; S Urakami; J P Cheadle; R Aspinwall; P Harris; J R Sampson; O Hino
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

2.  Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.

Authors:  K S Au; J A Rodriguez; J L Finch; K A Volcik; E S Roach; M R Delgado; E Rodriguez; H Northrup
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene.

Authors:  T Kobayashi; H Mitani; R Takahashi; M Hirabayashi; M Ueda; H Tamura; O Hino
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.

Authors:  H Onda; A Lueck; P W Marks; H B Warren; D J Kwiatkowski
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.

Authors:  F Jin; R Wienecke; G H Xiao; J C Maize; J E DeClue; R S Yeung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

6.  Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model.

Authors:  T Kobayashi; S Urakami; Y Hirayama; T Yamamoto; M Nishizawa; T Takahara; Y Kubo; O Hino
Journal:  Jpn J Cancer Res       Date:  1997-03

7.  TSC1 controls distribution of actin fibers through its effect on function of Rho family of small GTPases and regulates cell migration and polarity.

Authors:  Maki Ohsawa; Toshiyuki Kobayashi; Hidehiro Okura; Takashi Igarashi; Masashi Mizuguchi; Okio Hino
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

8.  Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.

Authors:  S Toyokuni; K Okada; S Kondo; H Nishioka; T Tanaka; Y Nishiyama; O Hino; H Hiai
Journal:  Jpn J Cancer Res       Date:  1998-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.